Resetting transcription factor control circuitry toward ground-state pluripotency in human.
Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A. · 2014
Read Resetting transcription factor control circuitry toward ground-state pluripotency in human. by Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4162745.txt.
Introduction
Yasuhiro Takashima, Austin Smith, and colleagues reset human pluripotent stem cells to a ground state resembling mouse embryonic stem cells. Their study appeared in Cell in 2014. Human cells in standard culture lack the control circuitry that keeps mouse cells in their most flexible, naive state.
Briefly switching on two factors, NANOG and KLF2, ignited the rest of the ground-state network. Blocking two signalling enzymes then sustained the rewired state without the added genes. Reset cells renewed themselves indefinitely, stayed chromosomally normal, and could still form all tissue types in tests. Their metabolism shifted toward mitochondrial breathing and their DNA methylation fell sharply. Removing ground-state factors collapsed the reset state but barely touched conventional cells, proving the circuitry had truly been installed.
Catalog record
| CREATOR | Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human By Yasuhiro Takashima, Ge Guo, Remco Loos, Jennifer Nichols, Gabriella Ficz, Felix Krueger, David Oxley, Fatima Santos, James Clarke, William Mansfield, Wolf Reik, Paul Bertone Published in: Cell DOI: 10.1016/j.cell.2014.08.029 ABSTRACT Summary Current human pluripotent stem cells lack the transcription factor circuitry that governs the ground state of mouse embryonic stem cells (ESC). Here, we report that short-term expression of two components, NANOG and KLF2, is sufficient to ignite other elements of the network and reset the human pluripotent state. Inhibition of ERK and protein kinase C sustains a transgene-independent rewired state. Reset cells self-renew continuously without ERK signaling, are phenotypically stable, and are karyotypically intact. They differentiate in vitro and form teratomas in vivo. Metabolism is reprogrammed with activation of mitochondrial respiration as in ESC. DNA methylation is dramatically reduced and transcriptome state is globally realigned across multiple cell lines. Depletion of ground-state transcription factors, TFCP2L1 or KLF4, has marginal impact on conventional human pluripotent stem cells but collapses the reset state. These findings demonstrate feasibility of installing and propagating functional control circuitry for ground-state pluripotency in human cells. INTRODUCTION Human pluripotent stem cells (PSC), derived from supernumerary embryos or by molecular reprogramming, show several distinguishing characteristics compared with paradigmatic mouse embryonic stem cells (ESC). Originally regarded as inconsequential species-specific features, increasing evidence suggests discrete developmental identities. Notably, derivation of postimplantation epiblast stem cells (EpiSC) (Brons et al., 2007, Tesar et al., 2007) shows that alternative pluripotent stem cells can be obtained from mice. EpiSC are related to primitive streak-stage late epiblast (Kojima et al., 2014, Tsakiridis et al., 2014). The terminology naive and primed was introduced to describe early and late phases of epiblast ontogeny and respective ESC and EpiSC derivatives (Nichols and Smith, 2009). Human PSC are considered more related to primed EpiSCs than to naive ESC. Mouse ESC self-renewal is favored by blockade of mitogen-activated protein kinase (Erk) signaling and is stimulated by the cytokine leukemia inhibitory factor (LIF) (Nichols and Smith, 2012). Combining two inhibitors (2i) of the Erk pathway and of glycogen synthase kinase-3 with LIF (2iL) provides a defined culture system that is effective for all strains of mouse and rat tested, supporting efficient ESC derivation and clonal expansion from dissociated cells (Boroviak et al., 2014, Ying et al., 2008). This serum- and growth-factor-free formulation is also selective; most cell types, including EpiSC and human PSC, differentiate or die in 2iL alone. The stability and relative homogeneity of ESC in 2iL (Wray et al., 2010) is postulated to represent a developmental ground state closely reflective of the newly formed epiblast in the mature blastocyst (Nichols and Smith, 2009). In contrast, EpiSC and human PSC are heterogeneous between and within cell lines (Kojima et al., 2014, Tsakiridis et al., 2014) and passage poorly when dissociated, resulting in low cloning efficiency. They are unresponsive to LIF but rely on growth factors, specifically fibroblast growth factor (FGF) and TGFβ/activin (Amit et al., 2000, Vallier et al., 2005). The transcriptional regulators Oct4 and Sox2 constitute the pillar of pluripotency through all its phases. These factors are essential but are not restricted to, nor sufficient for, the ESC ground state. A select group of regulators present in the preimplantation epiblast and ESC interconnect with Oct4/Sox2 to confer and sustain naive status. Foremost among these are Nanog, Klf2, Klf4, Esrrb, and Tfcp2l1 (Dunn et al., 2014, Ivanova et al., 2006, Martello et al., 2013, Niwa et al., 2009, Ye et al., 2013). Apart from Nanog, these factors are expressed at very low levels or are absent from EpiSC and human PSC. Strikingly, however, transfection of EpiSC with a single component in conjunction with transfer to 2iL can ignite the entire circuitry and reset the ESC ground state (Guo et al., 2009, Hanna et al., 2009, Silva et al., 2009). Conversion of mouse EpiSCs to ESC may provide a paradigm for generation of human ground-state PSC. Early trials (Hanna et al., 2010, Wang et al., 2011) noted ESC-like morphology, but cells appeared unstable. More recently, complex culture formulations have been proposed to allow propagation of human PSC with altered characteristics (Chan et al., 2013, Gafni et al., 2013, Ware et al., 2014), but these cells remain dependent on FGF, TGFβ, and/or serum replacement factors and lack evidence for rewiring of transcriptional control circuitry. We therefore investigated further the generation and stabilization of human cells with phenotypic features and transcription factor governance characteristic of ground-state pluripotency. RESULTS NANOG and KLF2 Reset the Human PSC Phenotype Expression of Nanog or Klf2 converts mouse EpiSC to ground-state ESC in 2iL (Hall et al., 2009, Silva et al., 2009). We tested the effect of this pair of factors in human embryo-derived H9 cells. We introduced doxycycline (DOX)-inducible KLF2 and NANOG/Venus constructs along with an rtTA vector. Transfectants were selected in conventional PSC culture medium (FGF/KSR) without DOX. Cultures were replated prior to addition of DOX. DOX-induced cells differentiated or died in FGF/KSR. In contrast, in 2iL undifferentiated cells persisted and formed colonies that could readily be expanded. These cells were positive for Venus, indicating robust transgene induction, and displayed the tightly packed domed appearance typical of mouse ESC in 2iL (Figure 1A). Cultures could be propagated continuously by enzymatic dissociation to single cells without requirement for ROCKi (Watanabe et al., 2007). On withdrawal of DOX, however, cultures degenerated unless transferred into FGF/KSR when they reverted to conventional flat PSC colony morphology and sensitivity to dissociation. Cells could be cycled between these two exclusive conditions (Figure 1A).Figure 1Resetting Human PSCData in this and other figures are from H9 cells unless otherwise indicated, but similar results were obtained from H1 and Shef6 cells and various iPS cell lines (Table S1 and Figure S1).(A) Induction or silencing of transgenes combined with switching between 2iL and FGF/KSR supports expansion of colonies with distinct morphology. Transgene expression indicated by the Venus reporter.(B) PKC inhibitor Gö6983 maintains colony morphology in the absence of transgene expression. Intrinsic fluorescence of Gö produces a faint red background signal.(C) Expansion in different CH concentrations. Cells were plated at 5 × 104 cells per well and were cultured for 4 days in PD03 with LIF and 0, 1, or 3 μM CH.(D) Cells previously cultured in t2iL with DOX were plated in 6-wells without ROCKi in conditions indicated and were stained after 10 days.(E) Cells maintained in t2iL+Gö were seeded in 12-well dishes without ROCKi in conditions indicated.(F) Cell proliferation data.(G) G-banded karyotype of reset cells at passage 16 (converted at parental passage 40).(H) qRT-PCR for pluripotency factor transcripts.(I) Immunostaining for ground-state pluripotency markers. The dot in the TFCP2L1 image of reset cells is due to intrinsic fluorescence of Gö.(J) Immunoblotting for ground-state pluripotency proteins in conventional and reset cells.(K) Reset cells on Matrigel or laminin 511-E8.(L) qRT-PCR for ground-state transcription factor transcripts in reset cells after five passages on Matrigel (Ma) or Laminin511-E8 (La). Cultures on MEF and conventional PSC on Matrigel in mTeSR are controls.Scale bars: (A and B) 100 μM, (I and K) 20 μM. Error bars indicate SD. We investigated candidate pathways for the ability to support propagation in 2iL upon DOX withdrawal. Addition of the protein kinase C (PKC) inhibitor